Navigation Links
New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy
Date:9/24/2008

PORTO, Portugal, September 24 /PRNewswire/ --

- Novel Treatment Also Demonstrated Significant Improvement in Quality of Life and Reduction in Depressive Symptoms

Positive data from three phase III studies presented today at the 8th European Congress of Epileptology, Berlin, Germany, demonstrated that Zebinix(TM) (1) (eslicarbazepine acetate), a novel once daily anti-epileptic agent, significantly reduced the frequency of partial seizures in patients with refractory partial epilepsy, in combination with other anti-epileptic agents.(2,3,4)

Zebinix(TM) is one of the proposed EU trade names for eslicarbazepine acetate.

In addition, treatment with Zebinix(TM) also significantly improved patient quality of life, reduced depressive symptoms and demonstrated sustained reduction in partial seizure frequency during a one-year open label period.(5,6,7)

"When assessing the potential of anti-epileptic agents it is as important to consider the implications on the quality of a patient's day-to-day life, as well as effective seizure control," said Professor E. Ben-Menachem, University of Goteborg, Sweden. "In addition to sustained reductions in seizure frequency, Zebinix(TM) also demonstrated a significant improvement in patient quality of life and reduction in depressive symptoms."

Professor Christian Elger, Director and Head of the Department of Epileptology at the University of Bonn, Germany, added "these data suggest that Zebinix(TM) may become an important treatment option for patients whose seizures are not adequately controlled with existing anti-epileptic agents."

Epilepsy is one of the most common neurological diseases affecting almost one in 100 people.(8) Treatment of partial seizures, the most common type of epilepsy, presents a constant challenge with over half of patients not achieving adequate seizure control with current anti-epileptic drugs.(9)

Zebinix(TM), a new anti-epileptic drug that selectively inh
'/>"/>

SOURCE BIAL
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma
2. Continuous Treatment With Abbotts HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment
3. Interface Biologics Anti-Thrombic Additives Show Equivalent Efficacy to Commercial Heparinized Coatings
4. NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
5. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
6. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
7. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
8. Medivation Presents Positive New Data on Dimebons Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimers Disease
9. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
10. Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
11. Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Attorney Advertising -- Bronstein, ... on behalf of purchasers of the securities of ... AMAG -News).  The investigation focuses on whether the ... On May 22, 2013, Shares of ... after the company announced in regulatory filing that ...
(Date:5/22/2013)... 22, 2013   Accuray Incorporated (Nasdaq: ... scheduled to present at the 2013 Jefferies Global Healthcare ... Thursday, June 6, 2013 at 1:30 p.m. EDT/10:30 a.m. ... will be available online from the Investor Relations page ... The webcast replay of the presentation will begin approximately ...
(Date:5/22/2013)... , May 22, 2013 JenaValve Technology, Inc., a ... implantation (TAVI) systems for the treatment of aortic valve disease, ... enaValve Eval U ation of Long Term P erformance ... E vere Ao R tic Stenosis (JUPITER) Registry at EuroPCR ... registry to evaluate five-year long term safety and effectiveness of ...
Breaking Medicine Technology:Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4
... 5, 2011 Oncimmune ® LLC, maker of EarlyCDT™-Lung ... assessment and early detection of lung cancer , today announces ... test: audit of 1,000 patients in clinical practice" supports ... with sensitivity for non-small cell lung cancer (NSCLC) at least as ...
... D. Smith, the fourth largest national pharmaceutical wholesaler, announced ... Bruin as corporate vice president managed care.  De Bruin ... and managed care experience, his senior and strategic-level pharmacy ... new position at H. D. Smith, de Bruin will ...
Cached Medicine Technology:First Reportable Data of EarlyCDT™-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer 2First Reportable Data of EarlyCDT™-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer 3First Reportable Data of EarlyCDT™-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer 4First Reportable Data of EarlyCDT™-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer 5H. D. Smith Appoints Mark de Bruin Corporate Vice President Managed Care 2
(Date:5/22/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- People who ... to attempt suicide, whether or not they also suffer ... new study. "Clinicians who are seeing patients with ... increased risk of suicide," said study co-author Mark Ilgen, ... and Evaluation Center in Ann Arbor, Mich. "Although ...
(Date:5/22/2013)... York (PRWEB) May 22, 2013 ... of the DePuy Pinnacle Hip Replacement System continue to ... Federal Court, Bernstein Liebhard LLP reports. According to ... DePuy Orthopaedics to produce monitoring reports associated with a ... company’s medical device marketing practices. Plaintiffs maintained in ...
(Date:5/22/2013)... According to a May 14, 2013 US News and ... Cancer Surgery,” modern medical technology has given women with ... a whole new light. Since the new approach known as ... cancer and mastectomies with greater hope for a positive ... plastic surgery to oncology, women had little choice but to ...
(Date:5/22/2013)... Michigan study challenges previous research that suggests umpire ... study, a collaboration between researchers at U-M and ... into the controversial argument over whether MLB umpires ... of the same race. It found little statistical ... associate professor of sport management at the U-M ...
(Date:5/22/2013)... By Maureen Salamon HealthDay Reporter , , WEDNESDAY, ... each cause a great deal of suffering, but new ... linked to something else entirely -- a smaller brain. ... double the risk of depression, scientists wanted to determine ... The difference in size -- about 2 percent -- ...
Breaking Medicine News(10 mins):Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3Health News:Breast Augmentation – New Option for Breast Cancer Surgeries 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 3
... ... Looks to Make an Impact as Inaugural President , ... Grand Rapids, Mich. (Vocus) October 29, 2009 -- Sanford-Brown Institute ... Amidon as its first campus president. Amidon comes to SBI - Grand Rapids from Baker ...
... CHICAGO, Oct. 29 Five-time Olympic gold medalist speed ... new, weekly fitness column for Tribune Media Services (TMS), ... publishers in the United States and abroad beginning Tuesday, ... , Each week Heiden will offer readers advice on ...
... Blue Cross and Blue Shield Association (BCBSA) issued the ... of healthcare reform legislation that would include a new ... and Blue Shield companies strongly support passing bipartisan comprehensive ... affordable coverage and rein in costs for everyone. ...
... Ohio, Oct. 29 Medicare Advantage plans in 95 ... the design of their 2010 medical and Part D ... Choice Gold Award recipients were selected from over 200 ... conducted annually by HealthMetrix Research Inc. and MedicareNewsWatch.com. ...
... , WASHINGTON, Oct. 29 The following is a statement from 60 ... a lie can travel half-way around the world before the truth can ... and is trying to catch up to Speaker Pelosi. I,m putting ... seniors by cutting half a trillion dollars from Medicare. ...
... Hanover, N.H.At its most benign, the autoimmune disease scleroderma can ... most pernicious, it can thicken and harden their skin, their ... killing them. , In all its forms, scleroderma gives Dartmouth ... a sense of urgency in their search for the triggers ...
Cached Medicine News:Health News:President Selected to Open Sanford-Brown Institute - Grand Rapids 2Health News:Eric Heiden Column To Debut November 3 2Health News:Eric Heiden Column To Debut November 3 3Health News:House Healthcare Bill: Government-Run Plan, Other Key Provisions Undermine Goals of Access and Affordability 2Health News:House Healthcare Bill: Government-Run Plan, Other Key Provisions Undermine Goals of Access and Affordability 3Health News:HealthMetrix Research Selects 2010 Medicare Advantage Plans for Best Overall Benefit Value 2Health News:HealthMetrix Research Selects 2010 Medicare Advantage Plans for Best Overall Benefit Value 3Health News:HealthMetrix Research Selects 2010 Medicare Advantage Plans for Best Overall Benefit Value 4Health News:Geneticists hunt for scleroderma triggers 2
... multiple core biopsies of soft tissue. Lightweight ... facilitates one-handed control. Precise, rapid firing mechanism ... stylet permits easy penetration into the specimen ... cutting edge of cannula helps assure an ...
... the iQ®200 Automated Urine Microscopy Analyzer ... Automated Urine Chemistry Analyzer (AX-4280) to ... microscopic analysis. The iQ200 uses Auto-Particle ... network, to classify and quantitate twelve ...
... The Iris Diagnostics iQ®200 Automated ... imaging and Auto-Particle Recognition (APR®) software ... categories and quantitatively report results. The ... to prepare and interpret particle images ...
... Alpha has been designed as a compact, ... hospitals, offices, private clinics or as a ... and the most commonly required investigations such ... included. Add-on options are available for ...
Medicine Products: